Back
Intellia Therapeutics Quote, Financials, Valuation and Earnings
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
24
NTLA
Intellia Therapeutics
Last Price:
21.17
Seasonality Move:
34.01%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.Intellia Therapeutics Price Quote
$21.17
Intellia Therapeutics Key Stats
Sell
24
Intellia Therapeutics (NTLA)
is a Sell
Day range:
$21.03 - $21.73
52-week range:
$20.78 - $47.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
52.17
P/B ratio:
1.94%
Volume:
857.9K
Avg. volume:
1.2M
1-year change:
-42.02%
Market cap:
$2B
Revenue:
$36.3M
EPS:
$-5.41
How Much Does Intellia Therapeutics Make?
-
How Much Are Intellia Therapeutics's Sales Annually?
NTLA Revenues are $36.3M -
How Much Profit Does Intellia Therapeutics's Make A Year?
NTLA net income is -$481.2M
Is Intellia Therapeutics Growing As A Company?
Data Unavailable
Intellia Therapeutics Stock Price Performance
-
Did Intellia Therapeutics Stock Go Up Last Month?
Intellia Therapeutics share price went down by -21.33% last month -
Did NTLA's Share Price Rise Over The Last Year?
NTLA share price fell by -42.02% over the past 1 year
What Is Intellia Therapeutics 52-Week High & Low?
-
What Is Intellia Therapeutics’s 52-Week High Share Price?
Intellia Therapeutics has traded as high as $47.48 over the past 52 weeks -
What Is Intellia Therapeutics’s 52-Week Low Share Price?
Intellia Therapeutics has traded as low as $20.78 over the past 52 weeks
Intellia Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Intellia Therapeutics?
-
How Much Debt Does Intellia Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intellia Therapeutics Have?
Cash and short term investments quarterly total is $912.2M -
What Is Intellia Therapeutics’s Book Value Per Share?
Book value per share is 11.29
Is Intellia Therapeutics Cash Flow Positive?
-
What Is NTLA Cash Flow From Operations?
Cash flow from operations (TTM) is -$394.1M -
What Is Intellia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $130.3M -
What Is Intellia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$31.3M
Intellia Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NTLA return on invested capital is -42.82% -
What Is Intellia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -35.35% -
What Is NTLA Return On Equity?
ROE is a measure of profitability and is -42.82%
Intellia Therapeutics Earnings Date & Stock Price
-
What Is Intellia Therapeutics's Stock Price Today?
A single share of NTLA can be purchased today for 21.17 -
What Is Intellia Therapeutics’s Stock Symbol?
Intellia Therapeutics trades on the nasdaq under the ticker symbol: NTLA -
When Is Intellia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Intellia Therapeutics is scheduled on May 3, 2024 -
When Is NTLA's next ex-dividend date?
Intellia Therapeutics's next ex-dividend date is April 25, 2024 -
How To Buy Intellia Therapeutics Stock?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intellia Therapeutics Competitors
-
Who Are Intellia Therapeutics's Competitors?
Below is a list of companies who compete with Intellia Therapeutics or are related in some way:
Intellia Therapeutics Dividend Yield
Data Unavailable
Intellia Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1.72% |
| Revenue: | 0% | -116.88% |
Analyst Recommendations
| Buy Recommendations: | 17 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 71.12 |
| Upside from Last Price: | 235.95% |